Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback